About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Decision Support System (CADIMS) for MS Diagnostic

NCT03205280·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Rennes University Hospital

With

Association Neuro-Bretagne
Institut National de Recherche en Informatique et en Automatique
Groupement de Coopération Sanitaire e-Santé Bretagne
Institut de Recherche Technologique b<>com

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

≥ 18 years-old
Patient with relapsing-remitting multiple sclerosis, according to the 2010 Mc Donald's criteria
EDSS\<4
Disease duration \< 10 years
To insure a clinical demand of 2 brain MRIs within 12 months of the installation of an immunomodulatory therapy
MRI brain scanner acquired according to the OFSEP recommendations installation of an immunomodulatory therapy

You may not be if

Progressive MS
no consent of the patient

The record

StatusCompleted

PhaseNo phase

Taking part200

StartedOct 2017

UpdatedApr 12, 2023

Conditions

Multiple Sclerosis, Relapsing-Remitting

Where5

Centre Hospitalier Bretagne Sud
Lorient, France
Centre Hospitalier Universitaire de Rennes
Rennes, France
Centre Hospitalier
Rennes, France

Clareo Health | Clinical Decision Support System (CADIMS) for MS Diagnostic